Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPNS vs Tolterodine Tartrate for Urgency-Frequency Syndrome
NCT02723279Completed
- Sponsor
- Shanghai Institute of Acupuncture, Moxibustion and Meridian
- Start
- Apr 2016
- Primary completion
- Oct 2016
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Shanghai Institute of Acupuncture, Moxibustion and Meridian. Primary endpoints: Lower urinary tract syndrome score at 6 weeks and Quality of life score at 6 weeks. Started Apr 2016; status: completed.
Beyond the preview
Go deeper on NCT02723279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02723279.